Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | butanal | increases expression | EXP | | 6480464 | butyraldehyde results in increased expression of XAGE2 mRNA | CTD | PMID:26079696 | cobalt dichloride | increases expression | EXP | | 6480464 | cobaltous chloride results in increased expression of XAGE2 mRNA | CTD | PMID:20105288 | cyclosporin A | increases methylation | EXP | | 6480464 | Cyclosporine results in increased methylation of XAGE2 promoter | CTD | PMID:27989131 | disodium selenite | decreases expression | EXP | | 6480464 | Sodium Selenite results in decreased expression of XAGE2 mRNA | CTD | PMID:18175754 | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | fonofos | increases methylation | EXP | | 6480464 | Fonofos results in increased methylation of XAGE2 promoter | CTD | PMID:22847954 | hydroquinone O-beta-D-glucopyranoside | increases expression | EXP | | 6480464 | Arbutin results in increased expression of XAGE2 mRNA | CTD | PMID:17103032 | mercury dibromide | increases expression | EXP | | 6480464 | mercuric bromide results in increased expression of XAGE2 mRNA | CTD | PMID:26272509 | mercury dibromide | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of XAGE2 mRNA | CTD | PMID:27188386 | parathion | increases methylation | EXP | | 6480464 | Parathion results in increased methylation of XAGE2 promoter | CTD | PMID:22847954 | permethrin | decreases expression | EXP | | 6480464 | Permethrin results in decreased expression of XAGE2 mRNA | CTD | PMID:37047231 | phenylmercury acetate | increases expression | EXP | | 6480464 | Phenylmercuric Acetate results in increased expression of XAGE2 mRNA | CTD | PMID:26272509 | resveratrol | multiple interactions | EXP | | 6480464 | [Plant Extracts co-treated with Resveratrol] results in decreased expression of XAGE2 mRNA | CTD | PMID:23557933 | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | sulforaphane | decreases expression | EXP | | 6480464 | sulforaphane results in decreased expression of XAGE2 mRNA | CTD | PMID:31838189 | terbufos | increases methylation | EXP | | 6480464 | terbufos results in increased methylation of XAGE2 promoter | CTD | PMID:22847954 | valproic acid | increases methylation | EXP | | 6480464 | Valproic Acid results in increased methylation of XAGE2 gene | CTD | PMID:29154799 | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of XAGE2 mRNA | CTD | PMID:26272509 | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of XAGE2 mRNA | CTD | PMID:27188386 | |